Healthcare - Drug Manufacturers - Specialty & Generic - NYSE - US
$ 8.47
-5.89 %
$ 3.91 B
Market Cap
-9.85
P/E
BALANCE SHEET
3.47 B
ASSETS
3.45 B
LIABILITIES
19.8 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Amneal Pharmaceuticals, Inc.
| Current Assets | 1.38 B |
| Cash & Short-Term Investments | 91.5 M |
| Receivables | 646 M |
| Other Current Assets | 641 M |
| Non-Current Assets | 2.09 B |
| Long-Term Investments | 37.1 M |
| PP&E | 550 M |
| Other Non-Current Assets | 1.51 B |
| Current Liabilities | 847 M |
| Accounts Payable | 146 M |
| Short-Term Debt | 228 M |
| Other Current Liabilities | 473 M |
| Non-Current Liabilities | 2.56 B |
| Long-Term Debt | 2.52 B |
| Other Non-Current Liabilities | 41.8 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||
| Cash & Cash Equivalents | 91.5 | 26.0 | 247.8 | 341.4 | 151.2 | 213.4 | 74.2 | 27.4 | 61.1 | |
| Short Term Investments | 2.2 | 1.8 | 1.2 | 1.7 | 1.1 | 2.1 | 1.9 | 4.4 | 5.0 | |
| Receivables | 645.7 | 741.8 | 662.6 | 674.2 | 635.9 | 565.3 | 351.4 | 394.8 | 273.8 | |
| Inventory | 581.4 | 530.7 | 489.4 | 490.6 | 381.1 | 457.2 | 284.0 | 266.2 | 235.0 | |
| Other Current Assets | 91.2 | 113.3 | 120.3 | 80.5 | 73.6 | 98.1 | 62.4 | 33.4 | 29.7 | |
| Total Current Assets | 1 377.9 | 1 411.8 | 1 520.1 | 1 551.5 | 1 210.2 | 1 286.6 | 771.9 | 726.1 | 604.6 | |
| PP&E | 550.1 | 589.4 | 639.0 | 595.2 | 609.2 | 544.1 | 486.8 | 407.4 | 318.8 | |
| Intangible Assets | 890.4 | 1 096.1 | 1 166.9 | 1 304.6 | 1 382.8 | 1 655.0 | 44.6 | 45.9 | 49.7 | |
| Goodwill | 598.6 | 598.9 | 593.0 | 522.8 | 419.5 | 426.2 | 26.4 | 28.4 | 29.8 | |
| Long Term Investments | 37.1 | 85.6 | 0 | 0 | 16.4 | 0 | 0 | 0 | 0 | |
| Other Long Term Assets | 18.4 | 103.2 | 20.6 | 31.9 | 44.3 | 67.6 | 11.3 | (481.8) | (398.3) | |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10.9 | 11.2 | |
| Total Assets | 3 472.6 | 3 799.3 | 3 939.7 | 4 006.0 | 3 665.9 | 4 352.7 | 1 341.9 | 1 218.8 | 1 014.1 | |
| LIABILITIES | ||||||||||
| Accounts Payable | 145.5 | 166.8 | 132.9 | 154.1 | 103.0 | 114.8 | 70.0 | 60.0 | 69.9 | |
| Short Term Debt | 227.6 | 104.6 | 46.0 | 57.5 | 37.0 | 21.7 | 89.5 | 37.0 | 59.7 | |
| Other Current Liabilities | 473.4 | 481.0 | 495.8 | 459.8 | 401.7 | 417.3 | 137.4 | 128.1 | 109.5 | |
| Total Current Liabilities | 846.6 | 752.8 | 677.2 | 676.9 | 550.4 | 553.9 | 296.9 | 225.1 | 239.1 | |
| Long Term Debt | 2 522.9 | 2 740.5 | 2 830.0 | 2 887.4 | 2 733.0 | 2 669.7 | 1 395.3 | 1 160.5 | 952.6 | |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 1.2 | 2.5 | 0 | 0 | |
| Other Liabilities | 41.8 | 97.1 | 65.4 | 96.8 | 35.7 | 231.7 | 10.3 | (0.9) | (1.0) | |
| Total Liabilities | 3 452.6 | 3 590.4 | 3 572.7 | 3 661.1 | 3 319.1 | 3 456.4 | 1 717.5 | 1 394.8 | 1 201.0 | |
| EQUITY | ||||||||||
| Common Stock | 3.1 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | 2.7 | 2.7 | 2.7 | |
| Retained Earnings | (490.2) | (406.2) | (276.2) | (286.8) | (377.9) | (20.9) | (382.8) | (175.2) | (182.0) | |
| Other Accumulative Comprehensive Income/Loss | (32.3) | 9.9 | (24.8) | (41.3) | 68 K | (7.8) | (14.2) | 0 | 0 | |
| Total Equity | 20.0 | 208.9 | 373.6 | 386.6 | 461.6 | 1 288.0 | (375.6) | (175.9) | (186.9) | |
| Total Liabilities and Equity | 3 472.6 | 3 799.3 | 3 939.7 | 4 006.0 | 3 665.9 | 4 352.7 | 1 341.9 | 0 | 0 | |
| SHARES OUTSTANDING | ||||||||||
| Common Shares Outstanding | 176.1 | 150.9 | 148.9 | 147.4 | 132.1 | 127.3 | 114.9 | 114.9 | 189.0 | 0 |